MTOR and cancer: We found that immune checkpoint genes (PD-1, IDO1 and LAG3) and cancer hallmarks (fatty acid metabolism, KRAS, P53, NOTCH, and PI3K/AKT/MTOR signaling pathway) showed significant differences between the two subgroups.